dc.contributor.author | Koc, Eylem Efe | |
dc.contributor.author | Himmetoglu, Solen | |
dc.contributor.author | Ataus, Suleyman | |
dc.contributor.author | Dincer, Yıldız | |
dc.contributor.author | Tuna, Mustafa Bilal | |
dc.date.accessioned | 2021-03-03T15:19:09Z | |
dc.date.available | 2021-03-03T15:19:09Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Himmetoglu S., Tuna M. B. , Koc E. E. , Ataus S., Dincer Y., "Serum levels of growth factors in patients with urinary bladder cancer", TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.42, sa.5, ss.571-575, 2017 | |
dc.identifier.issn | 0250-4685 | |
dc.identifier.other | av_3e5c9aac-8a19-4e9f-8b8c-17bf575140ac | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/45786 | |
dc.identifier.uri | https://doi.org/10.1515/tjb-2016-0129 | |
dc.description.abstract | Background: Altered signalling of human epidermal growth factor receptor-2 (HER-2/neu), insulin-like growth factor 1 (IGF-1) and epidermal growth factor (EGF) have been shown to play important role in tumor development and progression in various cancers. Their serum levels may be reliable indicator for diagnosis and progression of cancer. | |
dc.language.iso | eng | |
dc.subject | Temel Bilimler | |
dc.subject | Sitogenetik | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.title | Serum levels of growth factors in patients with urinary bladder cancer | |
dc.type | Makale | |
dc.relation.journal | TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 42 | |
dc.identifier.issue | 5 | |
dc.identifier.startpage | 571 | |
dc.identifier.endpage | 575 | |
dc.contributor.firstauthorID | 45244 | |